Injectable HIV Prevention Drug

WASHINGTON D.C. — (12-20-21) — The Food and Drug Administration announced on Monday that they have approved the first long-acting injectable HIV prevention medication for use as pre-exposure prevention, or PrEP, against HIV. The Following is the Official Statement Released by the FDA: Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable [...]